ONAKTA DIN 02537818
Health Canada record
| Active ingredient(s) | TIRBANIBULIN 1 % |
|---|---|
| Dosage form | Ointment |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D06BX OTHER CHEMOTHERAPEUTICS |
| Original market date | |
| Current status date | 12-May-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Avir Pharma Inc. — licence 3-002361, currently licensed, last inspection rating C (2025-07-07).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 30717 | 2023-05-12 | New Drug Submission (NDS) |
International API supply for TIRBANIBULIN
4 active FDA Drug Master Files.
Request a quote for ONAKTA